Kate Rosenbluth is the Founder, President & Chief Innovation Officer at Cala Health. Kate has worked in advanced neurotherapies for over 20 years and holds more than 60 patents and peer-reviewed publications, including inventing cutting-edge technologies with Brainlab, AskBio (Bayer), General Electric, and Genentech. Kate completed postdoctoral fellowships in UCSF Neurosurgery and Stanford Biodesign, a PhD from UC Berkeley and UCSF, and is an adjunct faculty member at her alma mater, Stanford University, where she teaches artificial intelligence and healthtech innovation.